CAS 897657-95-3

Formule : C16H16N6

InChI : InChI=1S/C16H16N6/c1-7-17-15(18-8-1)21-11-13-3-5-14(6-4-13)12-22-16-19-9-2-10-20-16/h1-10H,11-12H2,(H,17,18,21)(H,19,20,22)

Code InChI : PXZXYRKDDXKDTK-UHFFFAOYSA-N

SMILES : C1=CN=C(N=C1)NCC2=CC=C(C=C2)CNC3=NC=CC=N3

MSX-122

CAS : 897657-95-3

Formule : C₁₆H₁₆N₆

Degré de pureté : 99%

Masse moléculaire : 292.3384

Ref: IN-DA00GU9P

MSX-122

CAS : 897657-95-3

MSX-122

Formule : C₁₆H₁₆N₆

Degré de pureté : ≥95%

Masse moléculaire : 292.34

Ref: 54-BUP10412

MSX-122

CAS : 897657-95-3

MSX-122 is a novel small molecule and partial CXCR4 antagonist, with potent inhibition of CXCR4/CXCL12 actions(IC50 = 10 nM).

Formule : C₁₆H₁₆N₆

Degré de pureté : 98.31% - 99.15%

Couleur et forme : Solid

Masse moléculaire : 292.34

Ref: TM-T3992

MSX-122

CAS : 897657-95-3

N,N'-(1,4-Phenylenebis(methylene))bis(pyrimidin-2-amine)

Formule : C₁₆H₁₆N₆

Degré de pureté : 99%

Masse moléculaire : 292.34

Ref: IN-DG630973

MSX-122

CAS : 897657-95-3

MSX-122 is a small-molecule inhibitor, which is synthetically derived through pharmaceutical research. It functions as an antagonist to hypoxia-inducible factor-1α (HIF-1α), a transcription factor pivotal in cellular response to low oxygen conditions. By inhibiting HIF-1α, MSX-122 effectively disrupts the transcriptional activation of genes involved in angiogenesis, metabolism, and survival pathways that are often upregulated in cancerous tissues.

Formule : C₁₆H₁₆N₆

Degré de pureté : Min. 95%

Masse moléculaire : 292.34 g/mol

Ref: 3D-XKB65795